Immunomic Therapeutics, Inc. (ITI) an HLB Company, is a privately-held, clinical-stage biotechnology company pioneering the development of vaccines through its proprietary technology platform UNITE®, which is designed to utilize the body's natural biochemistry to develop vaccines that generate broad immune responses. ITI is primarily focused on applying the UNITE® platform to oncology indications, where it could potentially have broad applications, including development of antigen-derived antibodies as biologics in several cancers. The company has built a pipeline leveraging UNITE® with programs in oncology, animal health, infectious disease, and allergy. Immunomic Therapeutics is growing our clinical team and are seeking a strategic and tactical Director of Clinical Operations to help advance our programs. The Director of Clinical Operations is responsible for providing leadership to ITI's programs and ensuring studies (Phase I-IV) are compliant with company goals, procedures, FDA regulations, GCP, ICH requirements and any other applicable regulations. The Director is also responsible for the development and implementation of clinical operations standards and applying best project management practices and incorporating continuous sponsor oversight to facilitate trial initiating, planning, executing, monitoring/controlling, and closing activities.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level